The initial report from the Massachusetts Board of Registration in Pharmacy
shows that New England Compounding Center was operating like a small drug
manufacturing plant but without following the strict quality and safety
oversight that would come if it had been treated like a manufacturer and
regularly inspected by the FDA.
Read more: Pharma Manufacturing, Pharmaceutical Manufacturing - Fierce Pharma Manufacturing http://www.fiercepharmamanufacturing.com/#ixzz2ALxk22nl
Subscribe: http://www.fiercepharmamanufacturing.com/signup?sourceform=Viral-Tynt-FiercePharma Manufacturing-FiercePharma Manufacturing
No comments:
Post a Comment